Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement

Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1867-1878. doi: 10.1007/s00210-023-02471-z. Epub 2023 Apr 3.

Abstract

The Cucurbitaceae family produces a class of secondary metabolites known as cucurbitacins. The eight cucurbitacin subunits are cucurbitacin B, D, E, I, IIa, L glucoside, Q, and R with the most significant anticancer activity. They are reported to inhibit cell proliferation, invasion, and migration; induce apoptosis; and encourage cell cycle arrest, as some of their modes of action. The JAK-STAT3, Wnt, PI3K/Akt, and MAPK signaling pathways, which are essential for the survival and apoptosis of cancer cells, have also been shown to be suppressed by cucurbitacins. The goal of the current study is to summarize potential molecular targets that cucurbitacins could inhibit in order to suppress various malignant processes. The review is noteworthy since it presents all putative molecular targets for cucurbitacins in cancer on a single podium.

Keywords: Antimetastatic; Apoptosis; Cell cycle arrest; Cucurbitacins; Invasion.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Cell Proliferation
  • Cucurbitacins / pharmacology
  • Cucurbitacins / therapeutic use
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology
  • Phosphatidylinositol 3-Kinases
  • Triterpenes* / pharmacology
  • Triterpenes* / therapeutic use

Substances

  • Cucurbitacins
  • Phosphatidylinositol 3-Kinases
  • Triterpenes